Finished
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer
NCT04573738 · Third Military Medical University · Updated 27 Nov 2023
- What is being tested
- Robotic assisted transanal total mesorectal excision; Laparoscopic assisted transanal total mesorectal excision
- For
- Rectal Cancer; Perioperative Complication
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 13 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 May 2017, ends 30 Sept 2021. Registered 5 Oct 2020.
- Results
- None posted yet.
In the researchers' words
Total mesorectal excision has greatly reduced the local recurrence rate of rectal cancer after colorectal surgery. Transanal total mesorectal excision(TaTME) is potentially a suitable option for patients with middle and low rectal cancer. Robotic systems are expected to develop the advantages of TaTME to overcome the limitations of laparoscopic surgery. This study aimed to investigate the safety and feasibility of robotic assisted transanal total mesorectal excision in patients with rectal cancer.
Sites
- Daping hospitalChongqing, Chongqing Municipality, China